Compound C inhibits vascular smooth muscle cell proliferation and migration in an AMP-activated protein kinase-independent fashion

Journal of Pharmacology and Experimental Therapeutics

Volumn 338, Issue 2, 2011, Pages 476-484

  Peyton, Kelly J ^a   Yu, Yajie ^a   Yates, Benjamin ^a   Shebib, Ahmad R ^a   Liu, Xiao Ming ^a   Wang, Hong ^b   Durante, William ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOIMIDAZOLE 4 CARBOXAMIDE 1 BETA RIBOFURANOSIDE; 6 [4 (2 PIPERIDIN 1 YLETHOXY)PHENYL] 3 PYRIDIN 4 YLPYRAZOLO[1,5 A]PYRIMIDINE; ADENOVIRUS VECTOR; CYCLIN A; CYCLIN D1; DRUG CARRIER; ENZYME ACTIVATOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; POLYMER; PROTEIN P21; PYRAZOLOPYRIMIDINE DERIVATIVE; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CAROTID ARTERY INJURY; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE SILENCING; MALE; MUTANT; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; VASCULAR SMOOTH MUSCLE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CAROTID ARTERIES; CELL MIGRATION INHIBITION; CELL PROLIFERATION; CELLS, CULTURED; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PYRAZOLES; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79960553358     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.181784     Document Type: Article

References (34)

1. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, and Cohen P (2007) The selectivity of protein kinase inhibitors: a further update. Biochem J 408:297-315.
2. de Borst GJ, Ackerstaff RG, de Vries JP, vd Pavoordt ED, Vos JA, Overtoom TT, and Moll FL (2007) Carotid angioplasty and stenting for postendarterectomy stenosis: long-term follow-up. J Vasc Surg 45:118-123.
3. Durante W, Schini VB, Catovsky S, Kroll MH, Vanhoutte PM, and Schafer AI (1993) Plasmin potentiates the induction of nitric oxide synthesis by interleukin-1β in vascular smooth muscle cells. Am J Physiol 264:H617-H623.
4. Dzau VJ, Braun-Dullaeus RC, and Sedding DG (2002) Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 8:1249-1256. (Pubitemid 35373556)
5. Emerling BM, Viollet B, Tormos KV, and Chandel NS (2007) Compound C inhibits hypoxic activation of HIF-1 independent of AMPK. FEBS Lett 581:5727-5731. (Pubitemid 350179784)
6. Fukui R, Amakawa M, Hoshiga M, Shibata N, Kohbayashi E, Seto M, Sasaki Y, Ueno T, Negoro N, Nakakoji T, et al. (2000) Increased migration in late G1 phase in cultured smooth muscle cells. Am J Physiol Cell Physiol 279:C999-C1007.
7. Fukui R, Shibata N, Kohbayashi E, Amakawa M, Furutama D, Hoshiga M, Negoro N, Nakakouji T, Ii M, Ishihara T, et al. (1997) Inhibition of smooth muscle cell migration by the p21 cyclin-dependent kinase inhibitor (Cip1). Atherosclerosis 132:53-59. (Pubitemid 27306739)
8. Gallo R, Padurean A, Jayaraman T, Marx S, Roque M, Adelman S, Chesebro J, Fallon J, Fuster V, Marks A, et al. (1999) Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 99:2164-2170. (Pubitemid 29196802)
9. Gershlick A, De Scheerder I, Chevalier B, Stephens-Lloyd A, Camenzind E, Vrints C, Reifart N, Missault L, Goy JJ, Brinker JA, et al. (2004) Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial. Circulation 109:487-493. (Pubitemid 38168511)
10. Granada JF, Ensenat D, Keswani AN, Kaluza GL, Raizner AE, Liu XM, Peyton KJ, Azam MA, Wang H, and Durante W (2005) Single perivascular delivery of mitomycin C stimulates p21 expression and inhibits neointima formation in rat arteries. Arterioscler Thromb Vasc Biol 25:2343-2348. (Pubitemid 41552652)
11. Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, Uchino K, Hammer MD, Wechsler LR, and Jovin TG (2006) Safety, feasibility, and shortterm follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 37:2562-2566. (Pubitemid 44454680)
12. Henderson JF, Paterson AR, Caldwell IC, Paul B, Chan MC, and Lau KF (1972) Inhibitors of nucleoside and nucleotide metabolism. Cancer Chemother Rep 2 3:71-85.
13. Hu Y, Zou Y, Dietrich H, Wick G, and Xu Q (1999) Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin. Circulation 100:861-868. (Pubitemid 29398886)
14. Igata M, Motoshima H, Tsuruzoe K, Kojima K, Matsumura T, Kondo T, Taguchi T, Nakamaru K, Yano M, Kukidome D, et al. (2005) Adenosine monophosphateactivated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ Res 97:837-844. (Pubitemid 41447135)
15. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
16. Jang JH, Lee TJ, Yang ES, Min do S, Kim YH, Kim SH, Choi YH, Park JW, Choi KS, and Kwon TK (2010) Compound C sensitizes Caki renal cancer cells to TRAILinduced apoptosis through reactive oxygen species-mediated down-regulation of c-FLIPL and Mcl-1. Exp Cell Res 316:2194-2203.
17. Jeremias A and Kirtane A (2008) Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention. Ann Intern Med 148:234-238. (Pubitemid 351665508)
18. Jin J, Mullen TD, Hou Q, Bielawski J, Bielawska A, Zhang X, Obeid LM, Hannun YA, and Hsu YT (2009) AMPK inhibitor Compound C stimulates ceramide production and promotes Bax redistribution and apoptosis in MCF7 breast carcinoma cells. J Lipid Res 50:2389-2397.
19. Karpurapu M, Wang D, Van Quyen D, Kim TK, Kundumani-Sridharan V, Pulusani S, and Rao GN (2010) Cyclin D1 is a bona fide target gene of NFATc1 and is sufficient in the mediation of injury-induced vascular wall remodeling. J Biol Chem 285:3510-3523.
20. Liu XM, Ensenat D, Wang H, Schafer AI, and Durante W (2003) Physiologic cyclic stretch inhibits apoptosis in vascular endothelium. FEBS Lett 541:52-56. (Pubitemid 36428916)
21. Liu XM, Peyton KJ, Shebib AR, Wang H, Korthuis RJ, and Durante W (2011) Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival. Am J Physiol Heart Circ Physiol 300:H84-H93.
22. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, et al. (2003) Sirolimuseluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315-1323. (Pubitemid 37186209)
23. Nagata D, Takeda R, Sata M, Satonaka SM, Suzuki E, Nagano T, and Hirata Y (2004) AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation 110:444-451. (Pubitemid 38993855)
24. Nam M, Lee WH, Bae EJ, and Kim SG (2008) Compound C inhibits clonal expansion of preadipocytes by increasing p21 level irrespectively of AMPK inhibition. Arch Biochem Biophys 479:74-81.
25. Orford JL, Selwyn AP, Ganz P, Popma JJ, and Rogers C (2000) The comparative pathobiology of atherosclerosis and restenosis. Am J Cardiol 86:6H-11H.
26. Peyton KJ, Ensenat D, Azam MA, Keswani AN, Kannan S, Liu XM, Wang H, Tulis DA, and Durante W (2009) Arginase promotes neointima formation in rat injured carotid arteries. Arterioscler Thromb Vasc Biol 29:488-494.
27. Peyton KJ, Reyna SV, Chapman GB, Ensenat D, Liu XM, Wang H, Schafer AI, and Durante W (2002) Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood 99:4443-4448. (Pubitemid 34627213)
28. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79:551-555.
29. Tulis DA, Durante W, Liu X, Evans AJ, Peyton KJ, and Schafer AI (2001) Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation 104:2710-2715. (Pubitemid 33108139)
30. Vucicevic L, Misirkic M, Janjetovic K, Harhaji-Trajkovic L, Prica M, Stevanovic D, Isenovic E, Sudar E, Sumarac-Dumanovic M, Micic D, et al. (2009) AMP-activated protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound C. Biochem Pharmacol 77:1684-1693.
31. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81:323-330.
32. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, Hoyng SA, Lin HY, Bloch KD, and Peterson RT (2008) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 4:33-41. (Pubitemid 350273653)
33. Zeller T (2007) Current state of endovascular treatment of femoro-popliteal artery disease. Vasc Med 12:223-234.
34. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174. (Pubitemid 32995375)